Where We're Headed
Current Focus
Medical Innovation is our active priority. Critical Resources and Private Equity remain part of our platform and are available to qualified partners on request.
Medical Innovation is our active priority. Critical Resources and Private Equity remain part of our platform and are available to qualified partners on request.
Building bridges between Swiss innovation and US healthcare markets.
Critical Resources remains an active area of our platform, developed in the background as opportunities arise through our network. See our full platform.
Our Medical Innovation initiative connects Swiss research excellence with US healthcare markets. We welcome discussions with institutional investors and family offices interested in MedTech and DeepTech opportunities.
Discuss This Opportunity